Genetic determinants of thoracic aortic stiffness and remodeling
胸主动脉僵硬度和重塑的遗传决定因素
基本信息
- 批准号:10322755
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptionAdultAgeAgingAortaAortic SegmentAwardBiologicalCaliberChestClinicalClinical InvestigatorClinical SciencesCollaborationsDataDepositionDevelopmentDistalDoctor of PhilosophyEFRACEchocardiographyElastinEnrollmentEnvironmentEpidemiologyEquationEquipmentExhibitsFacultyFailureFibrosisGenerationsGenetic DeterminismGenetic studyGenomicsGoalsHealthHeart failureHeritabilityHumanImageIndividualK-Series Research Career ProgramsLeadershipLeftLengthLocationMagnetic Resonance ImagingMeasurementMeasuresMedicineMendelian randomizationMentorsMentorshipMethodologyMethodsMuscleParticipantPathologic ProcessesPatientsPennsylvaniaPhenotypePhysiciansPhysiologic pulsePlayPopulationPopulation StudyPrevention approachProcessProductivityProfessional OrganizationsResearchResearch PersonnelResourcesRespiratory DiaphragmRestRoleSample SizeScienceScientistSiteSurfaceSystemThoracic aortaTimeTrainingTraining SupportTranslational ResearchUniversitiesVentricularWorkage relatedaging populationaortic valvearterial tonometryascending aortabasebiobankburden of illnesscalcificationcareercareer developmentclinical imagingclinical practicedeep learningelectric impedanceepidemiology studyexomeexperiencegenome wide association studygenomic datahemodynamicsimaging studyimprovedinfancyinnovationinsightinterestlarge datasetsmedical schoolsmeetingsmid-career facultymultidisciplinarynext generationnext generation sequencingnovelpatient orientedpatient oriented researchpreservationprogramsprospectiveresearch and developmentresearch studyskillssuccesstime useultrasound
项目摘要
Project Summary / Abstract
This is an application for a K24 mentoring award for patient-oriented research (POR) from Julio Chirinos, MD,
PhD, Associate Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania
(Penn). Dr. Chirinos‘ long-term goals are to: (1) Substantially contribute to our understanding and approaches to
the prevention and treatment of aortic aging and its associated disease burden, and; (2) to mentor the next
generation of investigators interested in the epidemiology of aortic aging and its consequences in human health.
This mid-career development award will be critical to help him achieve these goals via dedicated/protected time
for mentoring activities, research and development of new skills that are anticipated to greatly enhance the
applicant’s impact in this field throughout the rest of his career, as well as the impact and success of his trainees.
The candidate has a strong record of mentorship, leadership, and research productivity. His research program
encompasses epidemiologic, translational and POR studies of arterial aging and its role in Heart Failure with
Preserved Ejection Fraction (HFpEF) and other conditions that afflict our aging population. The scientific goal of
this proposal is to investigate the genetic determinants of age-related thoracic aortic stiffening and elongation
using large available biobanks with associated genomic and aortic imaging data. These include the UK Biobank
and the Penn Medicine Biobank. The projects will include the application of a novel method for quantification of
aortic pulse wave velocity that can, for the first time, be applied retrospectively in widely available clinical imaging
studies. Deep learning for high-throughput aortic phenotyping will play an important role in this research. The
mentoring goals of this application are to engage and support the training of Penn fellows and junior faculty to
conduct POR in arterial aging. The career development goal of this application is to support the candidate’s
professional development and acquisition of new skills for POR research in aging, specifically: (1) genomics
(genome-wide association studies, next generation sequencing, and Mendelian Randomization); (2) Applied
deep learning to leverage large banks of imaging data in order to accomplish accurate high-throughput
phenotyping of aortic aging. This will be achieved through formal training courses and engaging in sustained
collaboration experiences with experts in these topics. The candidate will also engage in career development
and promotion of arterial aging research through convening scientific meetings on aortic aging research and
improving the national network of POR research in arterial aging through existing professional societies. The
institutional environment for clinical and translational science at Penn is outstanding. The Department of
Medicine at Penn has made a substantial commitment, including protected time and dedicated space, toward
the candidate’s sustained success as a patient-oriented researcher responsible for training a new generation of
junior investigators who conduct research in older participants.
项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULIO ALONSO CHIRINOS MEDINA其他文献
JULIO ALONSO CHIRINOS MEDINA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULIO ALONSO CHIRINOS MEDINA', 18)}}的其他基金
Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors
COVID-19 幸存者的心血管风险、血管和肾脏损伤
- 批准号:
10364096 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors
COVID-19 幸存者的心血管风险、血管和肾脏损伤
- 批准号:
10553207 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Efficacy of Fenofibrate for COVID-19: A phase II randomized controlled trial
非诺贝特对 COVID-19 的疗效:II 期随机对照试验
- 批准号:
10245967 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Genetic determinants of thoracic aortic stiffness and remodeling
胸主动脉僵硬度和重塑的遗传决定因素
- 批准号:
10539295 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical Centers
HeartShare:定义心力衰竭亚型和治疗目标的下一代表型组学 - 临床中心
- 批准号:
10679106 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical Centers
HeartShare:定义心力衰竭亚型和治疗目标的下一代表型组学 - 临床中心
- 批准号:
10327536 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Efficacy of Fenofibrate for COVID-19: A phase II randomized controlled trial
非诺贝特对 COVID-19 的疗效:II 期随机对照试验
- 批准号:
10459754 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets - Clinical Centers
HeartShare:定义心力衰竭亚型和治疗目标的下一代表型组学 - 临床中心
- 批准号:
10483139 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
Efficacy of Potassium Nitrate in Heart Failure with Preserved Ejection Fraction
硝酸钾治疗射血分数保留的心力衰竭的疗效
- 批准号:
8963158 - 财政年份:2015
- 资助金额:
$ 19.5万 - 项目类别:
Efficacy of Potassium Nitrate in Heart Failure with Preserved Ejection Fraction
硝酸钾治疗射血分数保留的心力衰竭的疗效
- 批准号:
9304280 - 财政年份:2015
- 资助金额:
$ 19.5万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Standard Grant














{{item.name}}会员




